CAS 2023788-19-2 Weight Loss Peptide GLP-1 Tirzepatide, 99% Purity Raw materials

NAME: Nancy

Whats App:+86 15226890287

Email:nancy@xtkstech.cn

Welcome to concult~

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor .

This medication is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels.

Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

NOTE: This product was prepared by chemical synthesis. Used only for research. 

1. The inhibitory effect  on glucagon

Tirzepatide can inhibit the secretion of glucagon, thereby reducing the amount of glucose released by the liver and lowering blood sugar levels. This inhibitory effect on glucagon is one of the unique mechanisms of action of tiesipatid, which helps to lower the blood sugar peak in diabetic patients and control blood sugar in the long term.

2. The weight management function 

Tirzepatide has the effect of suppressing appetite and increasing a sense of fullness . Through the action of the central nervous system, the gastric emptying time is prolonged and the food intake is reduced, thereby achieving the goal of weight loss. This gives tiesipatide a unique advantage in the treatment of Tirzepatide. It can not only improve blood sugar control but also promote weight loss.

3. The cardiovascular protective effect 

People with diabetes have an increased risk of cardiovascular complications. Cardiovascular protection is an important goal in the treatment of diabetes. Tirzepatide can reduce the presence of cardiovascular risk factors through multiple pathways, such as improving blood sugar control, reducing weight, and enhancing lipid metabolism.

Hongbai Technology Co., Ltd. is  a branch of Changsha Dolo Technology Co., Ltd.，which is a pioneering force in the biotechnology sector.

At the core of our operations is the unwavering commitment to our guiding principles : "Quality First, Service Supreme."Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

Our primary focus encompasses a range of products , including weight loss peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Tirzepatide, Retatrutide, and others.Provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the Clients.We have professional sales team , focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.

With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers .